Pharmaceutical Imports, Commerce & CBP Tariffs & that dreaded number: “232”

Episode Summary: In this episode, Benjamin L. England discusses recent developments in pharmaceutical imports, commerce, and CBP tariffs, particularly focusing on Section 232 investigations and reciprocal tariffs. The conversation covers the Department of Commerce's role in regulating international trade and its recent investigation into pharmaceutical imports.   Key Timestamps: 00:00 - Show Introduction 00:34 - Discussion of reciprocal tariffs and previous predictions 03:53 - China's retaliation and precious metals trade 05:22 - Department of Commerce's role in trade regulation 08:21 - How Commerce investigations are initiated 11:10 - Impact on pharmaceutical development and import/export 15:24 - Future predictions for international trade relations   About the Show: FDA Imports Cross-Border Compliance with Attorney Benjamin L. England is a podcast that explores legal challenges, compliance issues, and regulations affecting global trade. The show provides expert insights into FDA-related products including foods, drugs, cosmetics, and medical devices.